Advanz Pharma
Signal active
Organization
Contact Information
Overview
ADVANZ PHARMA is a global pharmaceutical company focussed on serving the needs of patients and healthcare providers around the world with enhanced access to high quality, niche established medicines. The Company has an international footprint with sales in more than 100 countries and has a diversified portfolio of more than 200 established, off-patent molecules that make up more than 1,300 SKUs. It also markets orphan drugs through its Orphan Drug Division, currently consisting of Photofrin for the treatment of certain rare forms of cancer, which is currently undergoing testing for potential new indications.
About
Industries
Health Care, Pharmaceutical, Hospital
Founded
1963
Employees
501-1000
Headquarters locations
Europe
Social
N/A
Profile Resume
Advanz Pharma headquartered in Europe, operates in the Health Care, Pharmaceutical, Hospital sector. The company focuses on Health Care and has secured $2.6B in funding across 36 round(s). With a team of 501-1000 employees, Advanz Pharma is actively contributing to advancements in Health Care. Their latest funding round, Post-IPO Equity - Advanz Pharma, raised $5.1M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
3
Investors
0
Lead Investors
0
Total Funding Amount
$72.7M
Details
0
Advanz Pharma has raised a total of $72.7M in funding over 0 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|
Investors
Advanz Pharma is funded by 12 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Canaccord Genuity Group | - | FUNDING ROUND - Canaccord Genuity Group | 67.6M |
| Beacon Securities | - | FUNDING ROUND - Beacon Securities | 67.6M |
| Advanz Pharma | - | FUNDING ROUND - Advanz Pharma | 67.6M |
| Cormark Securities Inc. | - | FUNDING ROUND - Cormark Securities Inc. | 67.6M |
Recent Activity
There is no recent news or activity for this profile.